Nippon India Pharma Fund vs Kotak Healthcare Fund compare
Kotak Healthcare Fund - Regular (G)
Nippon India Pharma Fund-Growth Plan-Growth Option
Chart Comparison
| Scheme Name | Kotak Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| Fund | Kotak Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
| Investment Plan | Growth | Growth |
| Level of Risk | Very High | Very High |
| Asset Size (Cr) | ₹406 Cr | ₹8689 Cr |
| Min Investment | ₹100 | ₹5000 |
| Min SIP Invesment | ₹100 | ₹500 |
| Min Addl Investment | ₹100 | ₹1000 |
| Launch Date | 11 Dec 2023 | 05 Jun 2004 |
| Category | Pharma & Healthcare | Pharma & Healthcare |
| Fund Type | Open Ended | Open Ended |
| Benchmark | NIFTY Healthcare TRI | BSE Healthcare |
| Turn Over | % | 21% |
| Expense Ratio | 2.39 | 1.81 |
| Manager | Abhishek Bisen | Sailesh Raj Bhan |
| ISIN Code | INF174KA1PW4 | INF204K01968 |
| Exits Load | Kotak Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 | Nippon India Pharma Fund - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 |
| Scheme Name | Kotak Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| 1 Month | -2.77% | -1.7% |
| 6 Month | 10.61% | 7.08% |
| 1 Year | 28.92% | 23.47% |
| 3 Year | - | 17.95% |
| 5 Year | - | 26.01% |
| Scheme Name | Kotak Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| 6 Month | - | - |
| 1 Year | 19.37% | 14.69% |
| 3 Year | - | 27.2% |
| 5 Year | - | 22.9% |
| Scheme Name | Kotak Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| 1 Year | - | 17.79% |
| 3 Year | - | 20.87% |
| 5 Year | - | 20.18% |
| Scheme Name | Kotak Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| Standard Deviation | - | 14.36% |
| Sharp | - | 0.78% |
| Beta | - | 0.87% |
| Alpha | - | 1.67% |
Still Confused Which Fund To Select? Don’t worry! We’re just a call away.
Get Free Experts Guidance
| Scheme Name | Kotak Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| Name | Abhishek Bisen | Sailesh Raj Bhan |
| Total AUM | ₹0 Cr | ₹96086 Cr |
| Fund Manage | 33 | 5 |
| Kotak Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
| Scheme Name |
Kotak Healthcare Fund - Regular (G) |
Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| Others | 3.31 | 4.4 |
| Small Cap | 24.27 | 22.52 |
| Large Cap | 51.29 | 45.96 |
| Mid Cap | 22.8 | 27.12 |
| Scheme Name |
Kotak Healthcare Fund - Regular (G) |
Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| Others | 3.31 | 4.4 |
| Pharmaceuticals & Biotechnology | 79.49 | 75.86 |
| Healthcare Services | 17.64 | 17.38 |
| Insurance | 1.23 | - |
| Retailing | - | 2.36 |
Top Comparisons
Franklin India ELSS Tax Saver Fund-Growth
3Y Returns15.2%
Tata ELSS Tax Saver Fund-Growth-Regular Plan
3Y Returns12.93%
Edelweiss Recently Listed IPO Fund Regular Plan Growth
3Y Returns7.42%
Sundaram Services Fund Regular Plan - Growth
3Y Returns13.31%
ICICI Prudential Credit Risk Fund - Growth
3Y Returns6.97%
Nippon India Credit Risk Fund - Growth Plan
3Y Returns6.74%
Canara Robeco Savings Fund - Regular Plan - Growth Option
3Y Returns6.15%
UTI Low Duration Fund - Regular Plan - Growth Option
3Y Returns6.45%